Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.

Wacker-Gußmann A, Bühren K, Schultheiss C, Braun SL, Page S, Saugel B, Schmid S, Mair S, Schoemig A, Schmid RM, Huber W.

AJR Am J Roentgenol. 2014 Feb;202(2):452-8. doi: 10.2214/AJR.13.10688.

PMID:
24450691
2.
3.

Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.

Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH.

Int J Cardiol. 2010 Feb 4;138(3):239-45. doi: 10.1016/j.ijcard.2008.08.013. Epub 2008 Sep 14.

PMID:
18793808
4.

A head-to-head comparison of homocysteine and cystatin C as pre-procedure predictors for contrast-induced nephropathy in patients undergoing coronary computed tomography angiography.

Li S, Tang X, Peng L, Luo Y, Zhao Y, Chen L, Dong R, Zhu J, Chen Y, Liu J.

Clin Chim Acta. 2015 Apr 15;444:86-91. doi: 10.1016/j.cca.2015.02.019. Epub 2015 Feb 14.

PMID:
25687162
6.

Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.

Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A, Schweigart U, Lutilsky L, Valina C, Seyfarth M, Schömig A, Classen M.

Am J Cardiol. 2003 May 15;91(10):1157-62.

PMID:
12745095
7.

Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization.

Ishibashi Y, Yamauchi M, Musha H, Mikami T, Kawasaki K, Miyake F.

Angiology. 2010 Nov;61(8):724-30. doi: 10.1177/0003319710379108.

PMID:
20947866
8.

Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization.

Kato K, Sato N, Yamamoto T, Iwasaki YK, Tanaka K, Mizuno K.

Circ J. 2008 Sep;72(9):1499-505.

9.

Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.

Tan N, Liu Y, Zhou YL, He PC, Yang JQ, Luo JF, Chen JY.

Catheter Cardiovasc Interv. 2012 Jan 1;79(1):70-5. doi: 10.1002/ccd.23048. Epub 2011 Oct 11. Erratum in: Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1256-7.

PMID:
21990069
10.

Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions.

Ribichini F, Gambaro G, Graziani MS, Pighi M, Pesarini G, Pasoli P, Anselmi M, Ferrero V, Yabarek T, Sorio A, Rizzotti P, Lupo A, Vassanelli C.

Clin Chem. 2012 Feb;58(2):458-64. doi: 10.1373/clinchem.2011.170464. Epub 2011 Dec 13.

11.

Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy.

Kim GS, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Jang Y.

J Vasc Surg. 2015 May;61(5):1223-30. doi: 10.1016/j.jvs.2014.11.079. Epub 2015 Jan 13.

PMID:
25595408
12.

Cystatin C as biomarker of contrast-induced nephropathy in pediatric cardiac angiography.

Osman Ö, Ayee Deniz O, Abdülkadir E, Cihat Ş, Hüsnü Oğuz S, Avse Banu Ç.

Turk J Med Sci. 2014;44(2):178-85.

PMID:
25536721
13.

Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.

Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F.

J Crit Care. 2013 Oct;28(5):701-9. doi: 10.1016/j.jcrc.2013.03.007. Epub 2013 May 15.

PMID:
23683568
14.

Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.

Merkle M, Sauter M, Argirov M, Wörnle M.

Ren Fail. 2010 Jan;32(1):85-90. doi: 10.3109/08860220903491216.

PMID:
20113272
15.

20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.

Torigoe K, Tamura A, Watanabe T, Kadota J.

Int J Cardiol. 2013 Sep 1;167(5):2200-3. doi: 10.1016/j.ijcard.2012.05.122. Epub 2012 Jun 19.

PMID:
22717305
16.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
17.

Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.

Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.

Angiology. 2014 May;65(5):436-42. doi: 10.1177/0003319713483918. Epub 2013 Apr 11.

PMID:
23580616
18.

High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.

Liu Y, Tan N, Zhou YL, Chen YY, Chen JY, Chen J, Luo JF.

J Nephrol. 2012 May-Jun;25(3):332-40. doi: 10.5301/jn.5000007.

PMID:
21928234
19.

Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography.

Shaker OG, El-Shehaby A, El-Khatib M.

Angiology. 2010 Nov;61(8):731-6. doi: 10.1177/0003319710373093. Epub 2010 Jun 7.

PMID:
20529972
20.

Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.

Kimmel M, Butscheid M, Brenner S, Kuhlmann U, Klotz U, Alscher DM.

Nephrol Dial Transplant. 2008 Apr;23(4):1241-5. doi: 10.1093/ndt/gfm785. Epub 2008 Jan 3.

Items per page

Supplemental Content

Write to the Help Desk